Livantra Gets Orphan Drug Designation for Pulmonary Arterial Hypertension
According to a story from BioSpace, Martin Pharmaceuticals' Livantra appears to be on something of a roll. Earlier in the year, the drug received Orphan Drug designation for the treating…